EMA finds potential link between AstraZeneca Covid-19 vaccine and blood clots
By Caoimhe Toman
Date: Wednesday 07 Apr 2021
(Sharecast News) - The European Medicines Agency said on Wednesday it had found a potential link between AstraZeneca's Covid-19 vaccine and blood clots in adults who had received the shot.
The EMA said it had taken into consideration all available evidence, according to Reuters.
"One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin," the watchdog said in a statement.
The regulator had backed the vaccine up until the prior week, saying there was no evidence of risk of blood clotting in general.
The news was a blow for the pharma company which is one of the most popular choices when it comes to acquiring shots to treat the illness.
EMA's safety committee, which was assessing the shot, had requested for more studies and changes to the current ones to get more information.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN